TSL Express Daily News

The Secured Lender

TSL-NOV24-COVR 

SFNet's 80th Annual Convention Issue
 

Intro content. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Curabitur iaculis sapien sagittis, accumsan magna ut, blandit massa. Quisque vehicula leo lorem, a tincidunt eros tempor nec. In quis lacus vitae risus egestas tincidunt. Phasellus nulla risus, sodales in purus non, euismod ultricies elit. Vestibulum mattis dolor non sem euismod interdum.

November 14, 2024

Source: Abacus Finance Group, LLC

New York, NY, November 14, 2024 – Abacus Finance Group, LLC – a leading provider of cash flow-based, classic senior debt for sponsor-led buyouts of lower middle-market companies – today announced that it served as Administrative Agent and Sole Lender to support WestView Capital Partners’ Dark Horse Consulting in its acquisition of BioTechLogic.  

 BioTechLogic, founded in 2003 and headquartered in Cave Creek, AZ, is a biopharmaceutical manufacturing and CMC consulting firm specialized in biologics, cell, and gene therapies. Dark Horse Consulting, founded in 2014 and headquartered in Walnut Creek, CA, is a consulting firm that provides development and regulatory services to clients working on cell and gene therapy products. WestView Capital Partners, a Boston-based growth equity firm, is focused on middle market growth companies and manages $2.7 billion in capital across multiple funds.

“Once again, Abacus was able to give us the certainty we needed to close the transaction in a short timeframe,” said WestView Partner Greg Thomas. “And they were able to provide us with a financing package that will help the company grow in the years ahead.”

“This is the 20th investment that we have closed with WestView since the inception of Abacus in 2011, a true testament to the strong partnership between our two firms,” said Tim Clifford, President and CEO of Abacus. “As in past transactions, we were able to provide speed and flexibility – key aspects of our Total Partnership Approach.” “WestView is without fail a strong partner and always great to work with,” added Abacus Managing Director & COO Sean McKeever.

Abacus team members involved in the transaction included Austin Rendell and Matthew Campanella. Legal counsel was provided to Abacus by Goulston & Storrs, PC.

About BioTechLogic, Inc.

BioTechLogic, a leading biopharmaceutical manufacturing and CMC consulting firm, was founded in 2003 by Peter Dellva, Patrick Giljum, and Tracy TreDenick and is headquartered in Cave Creek, AZ. The BioTechLogic consulting team, rich in practical and hands-on experience, reliably helps biopharma clients bring their products to market quickly and successfully by augmenting and optimizing an organization's technical, manufacturing, analytical, and regulatory resources. For more information, please visit   biotechlogic.com.

About Dark Horse Consulting Group

Dark Horse Consulting Group, a global company with offices in the United States, United Kingdom, and Singapore, was founded in 2014 with the purpose of accelerating cell and gene therapies through unmatched consulting expertise. DHC’s collective knowledge spans development, manufacturing, compliance, quality, regulatory, modeling, and business strategy, addressing a diverse range of client needs. For more information, please visit darkhorseconsultinggroup.com.

About WestView Capital Partners

WestView Capital Partners, a Boston-based growth equity firm, is focused on middle market growth companies and manages $2.7 billion in capital across five funds. WestView partners with existing management teams to sponsor minority and majority recapitalizations, growth capital, and consolidation transactions in several sectors including business services, IT services, healthcare technology and outsourcing, software, and growth industrial. WestView targets investing $20 to $100 million in companies with revenue of at least $10 million and operating profits between $3 and $25 million. For more information, please visit wvcapital.com.

About Abacus Finance Group, LLC

Abacus Finance is a leading direct lending company, focused on providing cash flow senior financing to private equity/family office-sponsored, lower middle-market companies across diverse industries. Since Abacus’s inception in 2011, it has closed over $3 billion in financings. The firm targets private debt financing opportunities of up to $50 million and finances companies with EBITDA between $3 million and $15 million. Abacus is an affiliate of New York Private Bank & Trust, which was founded in 1850.

Abacus Finance is located at 22 Vanderbilt Avenue, 5th Floor, New York, NY 10017. All inquiries and new investment opportunities should be directed to Tim Clifford at 212-850-462 or cliffordt@abacusfinance.com. Please visit abacusfinance.com for more information.

The Total Partnership Approach™, a registered trademark of Abacus Finance, LLC, brings together cash-flow financing expertise, deep industry knowledge and exceptional client service over the lifecycle of each investment – all providing our sponsors with certainty of close and giving them peace of mind. Our team’s deep industry knowledge combined with an obsession for efficiency results in a turnaround time of under 72 hours. This swift response time is just one aspect of our Total Partnership Approach™ – a comprehensive methodology that reflects our emphasis on growing relationships rather than just focusing on the number of transactions.

Why should you Count on Us?™ The answer lies in the deep partnerships we forge by going well above and beyond what sponsors traditionally have come to expect. We don’t believe in the phrase “good enough.” We push ourselves to create custom financing solutions tailored for each company – deals are started from the ground up, and we work side-by-side with the private equity sponsors we serve during each stage of the transaction life cycle.